Microfluidics Market Size Worth USD 77.28 Billion in 2030 Emergen Research
Rapid technological advancements in microfluidics, Point-of-Care testing, and IVD are key factors driving microfluidics market revenue growth.
According to Emergen Research, the global microfluidics market is expected to reach USD 20.14 billion in 2021, with a revenue CAGR of 16.1% during the forecast period. Rapid technological advancements in the field of microfluidics, such as Point-of-Care Testing (PoCT) and In-Vitro Diagnostics (IVD), significant investments in R&D activities, rising demand for microfluidic platforms for early disease detection and pathogen identification, and expanding applications of microfluidic platforms in various healthcare industries are factors driving market revenue growth.
The use of microfluidics in diagnostics is expanding, particularly in point-of-care diagnostics. This is supplemented by microfluidics-integrated biosensor technologies, which are expected to improve point-of-care diagnostics. The combination of microfluidic components and POC devices is primarily concerned with achieving sensitivity, stability, accuracy, affordability, and minimally invasive POC technology.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/35
Some Key Highlights from the Report
The polymer segment accounted for a significantly robust revenue share in 2021. Increasing demand from the packaging industry due to low cost and well-maintained fabrication techniques, for which polymers are favored is a key factor driving revenue growth of this segment. Poly(dimethylsiloxane) (PDMS) is a preferred choice from among these materials and has been widely used in microfluidics for fast and quick prototyping reasons, as it is easy to make and adheres tightly to glass and PDMS substrates with greater and improved optical transparency and elastomeric characteristics. Two perfluorinated polymers are utilized to construct microfluidic devices and structures, perfluoroalkoxy (Teflon PFA) and fluorinated ethylenepropylene (Teflon FEP), as these maintain their elastomeric and inertness, which makes them suitable for microfluidic platforms.
The microfluidic chip segment accounted for a significantly large revenue share in 2021. Microfluidic chips ae based on miniaturization technology to enable entire biochemical processes including reagent loading, reaction, separation, and detection, to be performed on a microchip. Densely interconnected microfluidic chips are small, portable, and only require a few consumables for early disease detection. Microfluidic technologies such as LOC technology, Three-Dimensional (3D) cell culture, organs-on-a-chip, and droplet techniques have advanced rapidly into various fields. Microfluidic chips, in combination with various detection techniques, are ideal for high-throughput drug testing, detection, and mechanistic research. These chips can be utilized in nanoparticle synthesis, drug encapsulation, delivery, targeting, cell analysis, and cell culture, either alone or in combination with other devices.
Asia Pacific market accounted for a moderate revenue share in 2021. Rising demand from biomedical and pharmaceutical sectors and in point-of-care testing, increased prevalence of chronic diseases, and increasing investments in R&D activities, particularly in Singapore, are key factors driving market revenue growth. For instance, a team of researchers from the University of Bristol has developed a novel low-cost and open-source 3D printing process for producing microfluidic devices. The process named Elsewhere, Developed by the Singapore University of Technology and Design, enables 3D printing of microfluidic devices integrated with fluid handling and functional components. Among the countries in Asia Pacific, China, Japan, and India account for majority revenue share contribution to the market in the region and the trend is expected to continue over the forecast period.
Emergen Research has segmented the global microfluidics market based on material type, application, component, and region:
Material Type Outlook (Revenue, USD Billion; 2019-2030)
Application Outlook (Revenue, USD Billion; 2019-2030)
Point-of-Care Testing (POCT) Diagnostics
Drug Delivery Systems
Pharmaceutical and Biotechnology Research
Components Outlook (Revenue, USD Billion; 2019-2030)
Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights